The article Dana-Farber submitted about Kevetrin will give us more specific info, I hope.
Maybe that's one of the reasons they want to keep going with the trial -- try to figure out how long the effect of a dose of Kevetrin lasts. Personally I would think that it would be less unpleasant to have infusions a couple of times a week than it would be to have a pump. But I could be wrong -- has anyone here had experience with or known anyone who had an insulin pump? How burdensome was that?
Maybe that's one of the reasons they want to keep going with the trial -- try to figure out how long the effect of a dose of Kevetrin lasts. Personally I would think that it would be less unpleasant to have infusions a couple of times a week than it would be to have a pump. But I could be wrong -- has anyone here had experience with or known anyone who had an insulin pump? How burdensome was that?